At the age of 34, the patient developed an invasive ductal carcinoma of the right breast (G2, ER and PgR positive, p185 3 + at biopsy), that was treated by neoadjuvant chemotherapy with carboplatin and taxol. This evidence concerns the gene EIF3A and invasive ductal breast carcinoma.